scholarly journals Evidence on acne therapy

2013 ◽  
Vol 131 (3) ◽  
pp. 193-197 ◽  
Author(s):  
Caroline Sousa Costa ◽  
Edileia Bagatin

Among the current treatments available for acne vulgaris, many widely practiced options lack support from studies at the best level of scientific evidence. The aim of this narrative review was to present the very latest information on topical and systemic treatments for acne vulgaris. Information from systematic reviews and well-designed clinical trials, obtained through a systematic search of the major medical databases, is emphasized. There are important issues regarding the clinical management of acne that still lack consistent grounding in scientific evidence. Among these are the optimum dose and duration of treatment with oral antibiotics that can be given without inducing bacterial resistance, and the safety of oral isotretinoin.

2020 ◽  
Vol 55 (1) ◽  
pp. 105-110
Author(s):  
Erin St. Onge ◽  
W. Cary Mobley

Objective: To review the safety and efficacy of minocycline 4% topical foam for the treatment of moderate to severe acne vulgaris in adults and pediatric patients aged 9 years and older. Data Sources: A literature search through PubMed and EMBASE was conducted using the following keywords: FMX101, minocycline, foam, and acne. Study Selection and Data Extraction: Articles selected included those describing preclinical and clinical studies of pharmacokinetics, efficacy, or safety of topical minocycline foam. Data Synthesis: Minocycline 4% topical foam was shown in a preclinical study to effectively deliver minocycline to the pilosebaceous unit, with little penetration beyond the stratum corneum. This was consistent with a phase 1 pharmacokinetic study of the foam, which yielded a significantly reduced systemic exposure of minocycline compared with oral minocycline. In phase 2 and phase 3 clinical trials, the foam significantly reduced acne lesion counts and Investigator’s Global Assessment scores of acne severity compared with placebo. The foam has a good safety profile, with headache, mild erythema, hyperpigmentation, and mild dryness among the most common adverse effects. Relevance to Patient Care and Clinical Practice: Topical antibiotics have been a mainstay of acne therapy with the benefit of less systemic exposure compared with oral antibiotics. However, the development of bacterial resistance has reduced their use, thereby reducing options for many patients with acne. Minocycline 4% topical foam is a safe and effective alternative, which may help restore this important therapeutic approach for treating acne vulgaris.


2021 ◽  
Vol 5 (1) ◽  
pp. 3-13
Author(s):  
Gabriela Teixeira ◽  
Stacy Ondina ◽  
Alexandre Bella Cruz ◽  
Tania Mari Bellé Bresolin

Acne affects most young people and its topical treatment with antibacterials is associated with increased bacterial resistance to antibiotics and adverse effects. As an alternative, ozone therapy stands out through the application of ozonized oils. The objective of this work was to raise the scientific evidence about the effectiveness in the treatment of acne, in addition to the techniques of characterization and stability of ozonated oils. This is an exploratory, descriptive study with a quantitative approach, based on the analysis of scientific references in a bibliographic review of the expository type, of the last 20 years. Among the selected references, only four manuscripts reporting clinical studies of ozone therapy, with controversial results. Seven articles with the physicochemical characterization of ozonated oils were found. The major part of manuscripts reported the use of sunflower, sesame and olive oil. The more common techniques used to characterize the ozonation process are the peroxide value (PV) and the iodine index (Ii), which represents the proportion of unsaturated groups, whose values increase and decrease, respectively with ozonization progress. The viscosity of oils is increased by the formation of polymeric peroxides; the FTIR spectrum, which identifies the decrease in the stretch bands C = C, in addition to ozone formation, monitored by NMR, are also employed. Increased antimicrobial activity has been demonstrated with the ozone level of the oils, but the activity against Cutibacterium acne has not been reported. Only two article reported satisfactory stability for 6 months of refrigerated ozonized oil or kept at room temperature, showing the need for more specific research to support the application of ozonized oils in the treatment of acne and stability data of these products.


Author(s):  
Zípora Santos ◽  
Maiara Velho ◽  
Fátima Zan ◽  
Virgínia Rech ◽  
Aline Ferreira Ourique

Acne vulgaris is a common skin disorder caused by inflammation and/or blockage of the pilosebaceous follicle. This research is a literature review study that is descriptive in nature and seeks to compile information on the factors related to the etiopathogenesis of the clinical manifestations of acne vulgaris. A survey was conducted in the Web of Science database in the period from January to May 2019, using the keywords "acne vulgaris, etiopathogenesis and pathophysiology". The etiopathogenesis of acne vulgaris is multifactorial, but most studies list the following factors: like diet, daily habits, age, genetics, abnormalities in the production of sebum, follicular hyperkeratinization, increased colonization by Cutibacterium (formerly Probionibacterium) acnes, periglandular dermal inflammation, oxidative stress and immune reactions of the patient. Topical and/or systemic treatments for acne vulgaris, often includes retinoid-associated antibiotics. However, improper use of these can lead to bacterial resistance, in addition, it may trigger adverse effects at epidermis and dermis. The results obtained in this study are important in relation to the treatment of the pathogenesis of acne vulgaris. It is believed that this information - when analyzed together - can help with a better definition of the therapeutic protocol.


2013 ◽  
Vol 88 (6 suppl 1) ◽  
pp. 193-196 ◽  
Author(s):  
Ariane Silva Bastos Geller ◽  
Roberta Ferreira Nazareth Alagia

Acne fulminans is a rare and severe form of acne that may evolve from acne vulgaris, especially in male adolescents, or occur as an adverse effect of oral isotretinoin. Arthritis is a serious clinical manifestation when the musculoskeletal system is compromised by AF and has been reported as a rare adverse effect of isotretinoin. Involvement of the sacroiliac joints occurs in 21% of acne fulminans cases. We present the case of a 18-year-old male patient in whom acne fulminans evolved from acne vulgaris grade IV and after inflammation resolution started treatment with oral isotretinoin. Within a 30-day period of retinoid treatment he presented with back pain followed by rapid, progressive inability to deambulate.


2014 ◽  
Vol 3 (1) ◽  
pp. 177 ◽  
Author(s):  
Mehrdad Rakhshanpour ◽  
Bahareh Abtahi-Naeini ◽  
MohammadAli Nilforoushzadeh ◽  
Gita Faghihi

2019 ◽  
Vol 21 (Supplement_6) ◽  
pp. vi222-vi222
Author(s):  
Tareq Juratli ◽  
Pamela Jones ◽  
Nancy Wang ◽  
Megha Subramanian ◽  
Simon Aylwin ◽  
...  

Abstract Craniopharyngiomas are surgically challenging brain tumors. Postoperatively, quality of life is often significantly impaired due to neurological and endocrinological complications. Currently, FDA approved systemic treatments are not available for patients in whom craniopharyngiomas recur after surgery and radiation. Papillary craniopharyngiomas are characterized by the presence of BRAFV600E mutations. To date, five case reports have been published on the treatment of BRAFV600E mutant papillary craniopharyngiomas with BRAF and/or MEK inhibitors. In this presentation, authors from all five previously published reports share their collective experience and provide updated follow-up on their patients, thus generating an overview of all currently available information on targeted therapy in patients with BRAFV600E mutant papillary craniopharyngiomas. We have also included information on an additional patient with a papillary craniopharyngioma recently treated with BRAF and MEK inhibitors after tumor biopsy alone, in the absence of recurrence, highlighting the potential for a neo-adjuvant therapeutic approach. All six cases in our series showed dramatic responses to targeted treatment with BRAF (and MEK) inhibitors. Collectively, our cases are highly promising and informative for patient treatment, although uncertainty remains with regards to the optimal timing, the specific agents (single agent or dual therapy) to be used and the duration of treatment. The ongoing multicenter phase II Alliance A071601 trial (NCT03224767) of vemurafenib and cobimetinib for patients with biopsy-proven residual or recurrent papillary craniopharyngiomas should provide additional information to help guide patient management.


2020 ◽  
Vol 2020 ◽  
pp. 1-5 ◽  
Author(s):  
Sharleen St. Surin-Lord ◽  
Judi Miller

Truncal acne is present in approximately half of all patients with facial acne but is also occasionally seen in isolation. Important considerations when selecting treatment options for adult female acne, whether on the face, back, chest, or shoulders, include patient compliance, treatment response time, tolerability of the treatment, and psychosocial impact of the disease. Oral antibiotics are widely prescribed for truncal acne due to the challenges of applying topical therapy to such an extensive body surface area. In cases of severe inflammatory and nodular acne vulgaris, this may be a reasonable consideration; however, oral antibiotics should only be used for short durations. Overprescription contributes to microbial resistance and may cause disruption of the gastrointestinal microbiome. In many cases of mild, moderate, or even severe truncal acne, combinations of topical therapies may be valid alternatives. The introduction of foam formulations with enhanced percutaneous absorption and tretinoin lotion formulations that incorporate moisturizing/hydrating agents challenges the previously held idea that effective and tolerable treatment of truncal acne requires oral treatment. This case series describes four female African-American patients with truncal acne successfully treated with a combination of tretinoin lotion 0.05% and azelaic acid 15% foam.


Sign in / Sign up

Export Citation Format

Share Document